SOLICITATION NOTICE
B -- access to national-level pharmaceutical sales data and International level sales data to estimate and forecast trends in pharmaceutical sales, pricing, and volume of distribution throughout various settings of care.
- Notice Date
- 9/1/2022 11:59:39 AM
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 518210
— Data Processing, Hosting, and Related Services
- Contracting Office
- FDA CENTER FOR DRUG EVALUATION AND RESEARCH Silver Spring MD 20993 USA
- ZIP Code
- 20993
- Solicitation Number
- 75F40122R00082
- Response Due
- 9/9/2022 11:00:00 AM
- Archive Date
- 09/24/2022
- Point of Contact
- Howard S. Yablon, Phone: 2404027630
- E-Mail Address
-
howard.yablon@fda.hhs.gov
(howard.yablon@fda.hhs.gov)
- Description
- FDA/CDER requires access to national-level pharmaceutical sales data and international-level pharmaceutical sales data� to estimate and forecast trends in pharmaceutical sales, pricing, and volume of distribution throughout various settings of care.� Continued access to these data allows the FDA to respond expeditiously to questions relating to drug safety, the impact of regulatory policies, and to potential drug shortage situations, helping the Agency to make more informed decisions about matters that affect the health of Americans. See Attachments for RFP and related attachments. Modification: See attachment for Contractor Questions and Government Responses. Bassed on the Contractor Questions, the Description Title for this requirement has been updated and the Solictation Document has been updated. Please see the document ""Solcitation updated 9 1 2022...""
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/5d04d18382c242c8b3277256a49f01c8/view)
- Place of Performance
- Address: Silver Spring, MD 20903, USA
- Zip Code: 20903
- Country: USA
- Zip Code: 20903
- Record
- SN06449921-F 20220903/220901230120 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |